After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Acrivon Therapeutics Inc is $40.14M. A total of 0.6 million shares were traded on the day, compared to an average of 735.00K shares.
In the most recent transaction, PERCEPTIVE ADVISORS LLC sold 437,881 shares of ACRV for 1.41 per share on Apr 30 ’25. After the transaction, the 10% Owner now owns 3,403,025 company shares. In a previous transaction on May 01 ’25, PERCEPTIVE ADVISORS LLC sold 298,886 shares at 1.34 per share. ACRV shares that 10% Owner owns now total 3,104,139.
Among the insiders who sold shares, PERCEPTIVE ADVISORS LLC disposed of 1,054,669 shares on Apr 25 ’25 at a per-share price of $1.95. This resulted in the 10% Owner holding 4,306,189 shares of ACRV after the transaction. In another insider transaction, PERCEPTIVE ADVISORS LLC sold 250,000 shares at $1.41 per share on Apr 29 ’25. Company shares held by the 10% Owner now total 3,840,906.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ACRV has a high of $10.16 and a low of $1.05.
As of this writing, ACRV has an earnings estimate of -$0.58 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.47 per share and a lower estimate of -$0.71.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ACRV’s latest balance sheet shows that the firm has $99.60M in Cash & Short Term Investments as of fiscal 2021. There were $5.63M in debt and $2.91M in liabilities at the time. Its Book Value Per Share was $5.12, while its Total Shareholder’s Equity was -$23.81M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACRV is Buy with a score of 4.78.
